drugset
drugset / Trial / NCT01088256

Efficacy of Etoricoxib on Peripheral Hyperalgesia

NCT01088256 ↗

Phase 2 Terminated 9 enrolled Ruhr University of Bochum
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to determine the efficacy of etoricoxib on pain patients. The investigators assume that patients with neuropathic pain will have greater pain relief then patients on placebo.

Timeline

Start
2011-02
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etoricoxib Small molecule 90 mg —

Indications

complex regional pain syndrome type 2 peripheral nerve lesion polyneuropathy postherpetic neuralgia radiculopathy